Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome

Development and validation of a questionnaire to measure asthma control

Juniper, E. F., O′byrne, P. M., Guyatt, G. H., Ferrie, P. J., & King, D. R. (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.14d29.x · Cited by 2,473

The American College of Rheumatology 1990 criteria for the classification of churg‐strauss syndrome (allergic granulomatosis and angiitis)

Masi, A. T., Hunder, G. G., Lie, J. T., Michel, B. A., Bloch, D. A., Arend, W. P., Calabrese, L. H., Edworthy, S. M., Fauci, A. S., Leavitt, R. Y., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330806 · Cited by 2,212

Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma

Haldar, P., Brightling, C. E., Hargadon, B., Gupta, S., Monteiro, W. R., Sousa, A. R., Marshall, R. P., Bradding, P., Green, R. H., Wardlaw, A. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808991 · Cited by 1,873

Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response

Leckie, M. J., Brinke, A. T., Khan, J., Diamant, Z., O'Connor, B. J., Walls, C. M., Mathur, A., Cowley, H., Chung, K. F., Djukanović, R., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03496-6 · Cited by 1,810

Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia

Nair, P. K., Pizzichini, M. M. M., Kjarsgaard, M., Inman, M. D., Efthimiadis, A., Pizzichini, E., Hargreave, F. E., & O’Byrne, P. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805435 · Cited by 1,346

Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.

Luqmani, R. A., BACON, P. A., Moots, R. J., Janssen, B. A., Pall, A. A., Emery, P., Savage, C. O. S., & Adu, D. (1994) · PubMed · Cited by 1,056

Interleukin-5, eosinophils, and disease

Sanderson, C. (1992) · Blood · doi:10.1182/blood.v79.12.3101.bloodjournal79123101 · Cited by 972

Interleukin-5, eosinophils, and disease

Sanderson, C. (1992) · Blood · doi:10.1182/blood.v79.12.3101.3101 · Cited by 860

Eosinophil's Role Remains Uncertain as Anti–Interleukin-5 only Partially Depletes Numbers in Asthmatic Airway

Flood-Page, P. T., Menzies-Gow, A. N., Kay, A. B., & Robinson, D. S. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200208-789oc · Cited by 808

A Study to Evaluate Safety and Efficacy of Mepolizumab in Patients with Moderate Persistent Asthma

Flood-Page, P. T., Swenson, C. A., Faiferman, I., Matthews, J. G., Williams, M. J. A., Brannick, L., Robinson, D. S., Wenzel, S. E., Busse, W. W., Hansel, T. T., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200701-085oc · Cited by 750

Marked neurological and immunological improvement in refractory eosinophilic granulomatous polyangiitis after treatment with mepolizumab, an anti‐interleukin‐5 antibody: A case report

Yasuda, M., Sugiyama, A., Suichi, T., Misawa, S., & Kuwabara, S. (2020) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12582 · Cited by 4

A 78-year-old woman with an acute eosinophilic gastroenteritis

Javelle, É., Gasperini, G., Mercier, J., Luciano, L., Sagui, E., Soulier, M., Kerebel, S., Lebougeant, P., Molinier, S., Guisset, M., et al. (2011) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2011.06.012 · Cited by 4

The role of biologics in treatment of ANCA-associated vasculitis

Dharmapalaiah, C., & Watts, R. A. (2011) · Modern Rheumatology · doi:10.1007/s10165-011-0548-y · Cited by 4

Terapia biológica en las vasculitis sistémicas

Díaz-Orta, M. A., & Rojas‐Serrano, J. (2011) · Reumatología Clínica · doi:10.1016/j.reuma.2011.09.001 · Cited by 4

Conditions in subjects with rheumatic diseases: pulmonary manifestations of vasculitides

Holle, J. U., Moosig, F., Dalhoff, K., & Gross, W. L. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3307 · Cited by 4

Immunotherapy in Eosinophilic Granulomatosis with Polyangiitis: A New Step Forward?

Puéchal, X. (2016) · Journal of Vasculitis · doi:10.4172/2471-9544.1000e106 · Cited by 3

New therapeutic approaches with biological drugs for eosinophilic granulomatosis with polyangiitis

Carrón‐Herrero, A., Pelaia, C., & Paoletti, G. (2023) · doi:10.37349/eaa.2023.00006 · Cited by 3

Application of biological agents in the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis

Liu, W., Tian, G., Chen, C., Zhang, M., Chen, Z., Chen, T., Lin, Z., Wu, W., Wu, Y., Wu, K., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1378384 · Cited by 3

Management of Severe Asthma in Eosinophilic Granulomatosis with Polyangiitis with Interleukin-5-Targeted Therapies: Current Status and Report of Two Cases

Romano, C. P., Cozzolino, D., Sellitto, A., & Rinaldi, L. (2022) · Applied Sciences · doi:10.3390/app122211535 · Cited by 3

Biologics in Hypereosinophilic Syndrome and Eosinophilic Granulomatosis with Polyangiitis

Ezekwe, E., Weskamp, A. L., Pittman, L. M., & Klion, A. D. (2024) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2024.07.003 · Cited by 3

Mepolizumab

Cada, D. J., Bindler, R. J., & Baker, D. E. (2016) · Hospital Pharmacy · doi:10.1310/hpj5105-405 · Cited by 3

Interleukins for the Paediatric Pulmonologist

Rozycki, H. J., & Zhao, W. (2013) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2013.04.006 · Cited by 3

Necrotizing eosinophilic granulomatous lymphadenitis with ring- and C-shaped granulomas—an underrecognized specific manifestation of nodal Churg-Strauss syndrome

Swanson, E. J., Manivel, J. C., Valen, P. A., & Mesa, H. A. (2017) · Journal of Hematopathology · doi:10.1007/s12308-017-0297-8 · Cited by 3

Eosinophile Granulomatose mit Polyangiitis (Churg-Strauss-Syndrom)

Jerrentrup, A., Müller, T., Mariß, J., & Dylla, S. (2017) · Der Internist · doi:10.1007/s00108-017-0303-3 · Cited by 3

Eosinophilic Lung Diseases

Cottin, V., & Cordier, J.-F. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-3383-5.00068-3 · Cited by 3

The Role of Omalizumab in Patients With Eosinophilic Granulomatosis With Polyangiitis (Churg‐Strauss): Comment on the Article by Jachiet et al

Detoraki, A., Varricchi, G., Genovese, A., Marone, G., & Spadaro, G. (2016) · Arthritis & Rheumatology · doi:10.1002/art.40012 · Cited by 3

Targeting Eosinophils in Eosinophilic Granulomatosis with Polyangiitis

Djukanović, R., & O’Byrne, P. M. (2017) · New England Journal of Medicine · doi:10.1056/nejme1704402 · Cited by 3

Improving patient outcomes: Mepolizumab’s impact in IL-5-mediated diseases

Gothi, D., Narasimhan, R., Guleria, R., Chopra, M., Gvalani, A., & Hegde, R. (2025) · Lung India · doi:10.4103/lungindia.lungindia_442_24 · Cited by 3

Hypereosinophilia-associated Diseases and the Therapeutic Agents in Development

Chung, I. Y. (2013) · Hanyang Medical Reviews · doi:10.7599/hmr.2013.33.1.65 · Cited by 2

Mécanismes de la granulomatose éosinophilique avec polyangéite (Churg-Strauss)

Terrier, B., Chaigne, B., & Guillevin, L. (2017) · Revue du Rhumatisme Monographies · doi:10.1016/j.monrhu.2017.04.001 · Cited by 2

Eosinophilic granulomatosis with polyangiitis treated with mepolizumab at a dose of 100 mg/month

Viviana, A. M., Cuestas, E. I., Albiero, J. A., Dillon, R. F., Betiana, L. P., Perrone, V. E., Guendulaín, S., Lugones, J. I., & Casas, J. P. (2020) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2019.09.008 · Cited by 2

Eosinophilic Lung Disease: Accompanied with 12 Cases

Sevim, T., Aksoy, E., Akyıl, F. T., Ağca, M., Kongar, N., & Özşeker, F. (2015) · Turkish Thoracic Journal · doi:10.5152/ttd.2015.4614 · Cited by 2

Eosinophile Granulomatose und Polyangiitis – Diagnostik und Therapie

Kroegel, C., Slevogt, H., Foerster, M., Ali, R., Neumann, T. E., & Costabel, U. (2018) · Der Pneumologe · doi:10.1007/s10405-018-0194-6 · Cited by 2

Hypersensitivity Pneumonitis and Eosinophilic Lung Diseases

Knutsen, A. P., Temprano, J., Bhatla, D., & Slavin, R. G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-44887-1.00065-1 · Cited by 2

Stratégies d’immunothérapie ciblée au cours des vascularites associées aux ANCA

Puéchal, X. (2018) · Revue du Rhumatisme · doi:10.1016/j.rhum.2018.06.005 · Cited by 2

Gastrointestinal Involvement of Systemic Vasculitis

Sato, S., & Migita, K. (2019) · Springer eBooks · doi:10.1007/978-981-13-6524-9_9 · Cited by 2

Pericardial effusion with tamponade – an uncommon presentation leading to the diagnosis of eosinophilic granulomatosis polyangiitis: A case report

Alam, L., Lasam, G. U., & Fishberg, R. D. (2020) · World Journal of Cardiology · doi:10.4330/wjc.v12.i9.460 · Cited by 2

Current Treatment of ANCA Vasculitis

Bouattour, Y., Snoussi, M., & Bahloul, Z. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.110375 · Cited by 2

Evidencia terapéutica del mepolizumab en la granulomatosis eosinofílica con poliangeítis: una revisión exploratoria

Tuta-Quintero, E., Perna-Reyes, I., Olivella-Gómez, J., Rodríguez-Fraile, D., Santacruz, J. C., Mayorga-Borja, A. A., & Londoño, J. D. (2024) · Revista Colombiana de Reumatología · doi:10.1016/j.rcreu.2023.11.003 · Cited by 1

Effectiveness of low-dose mepolizumab in refractory eosinophilic granulomatosis with polyangiitis: systemic steroid use and remission

Kim, M., Lee, J.-H., Kim, E.-K., Kim, J.-H., Park, J., Lee, S. H., & Kim, T.-B. (2026) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2025.130 · Cited by 1

Update Churg-Strauss-Syndrom

Moosig, F., & Hellmich, B. (2012) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-012-0985-9 · Cited by 1

SY6_1

Walsh, M. (2017) · Lara D. Veeken · doi:10.1093/rheumatology/kex114 · Cited by 1

Therapeutic evidence of mepolizumab in eosinophilic granulomatosis with polyangiitis: A scoping review

Tuta-Quintero, E., Perna-Reyes, I., Olivella-Gómez, J., Rodríguez-Fraile, D., Santacruz, J. C., Mayorga-Borja, A. A., & Londoño, J. D. (2024) · Revista Colombiana de Reumatología (English Edition) · doi:10.1016/j.rcreue.2024.11.008 · Cited by 1

Hypereosinophilic syndrome and Churg-Strauss syndrome Spectrum of the same disease? New concepts

Jaime, C. A. A. (2014) · Acta Médica Colombiana · Cited by 1

Pulmonary Manifestations of Vasculitis

Specks, U. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0770-0_10 · Cited by 1

Vasculitis de mediano vaso. Vasculitis necrotizantes: panarteritis nodosa y vasculitis ANCA asociadas. Enfermedad de Kawasaki

Mestre-Torres, J., Valle, F. M., & Solans, R. (2017) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2017.03.003 · Cited by 1

A case with nodular airway lesions misdiagnosed as difficult-to-treat asthma

Zhao, F., Jiang, Y., Ma, S., Zhang, W., & Jiang, Y. (2019) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2019.05.005 · Cited by 1

Granulomatose éosinophilique avec polyangéite : pathogénie et conséquences thérapeutiques

Terrier, B. (2019) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2019.10.015 · Cited by 1

Granulomatosis eosinofílica con poliangeítis tratada con mepolizumab en dosis de 100 mg/mes

Moyano, V., Cuestas, E. I., Albiero, J. A., Dillon, R. F., Pereyra, B., Perrone, V. E., Guendulaín, S., Lugones, J. I., & Casas, J. P. (2020) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2019.09.019 · Cited by 1

Multiple hepatic aneurysms and dry gangrene of fingertips in eosinophilic granulomatosis with polyangiitis: a case report

Koh, E., Kang, N., Lee, J.-Y., Kim, D., Do, Y. S., Lee, B., & Choi, D. (2020) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-020-00484-4 · Cited by 1

Treatment of ANCA-Associated Vasculitides

Guillevin, L., Raffray, L., Nguyen, Y., Chaigne, B., & Terrier, B. (2019) · Rare diseases of the immune system · doi:10.1007/978-3-030-02239-6_17 · Cited by 1

Earlier continuous administration of mepolizumab for eosinophilic granulomatosis with polyangiitis based on cutaneous findings

Ikeda, T., Komatsu, T., Yokoyama, K., & Kawakami, T. (2023) · Journal of Cutaneous Immunology and Allergy · doi:10.1002/cia2.12295 · Cited by 1

Churg Strauss Syndrome: Clinical and Pathogenetic Approach to Therapy

Rolla, G., Boita, M., Heffler, E. M., & Gui, G. (2011) · InTech eBooks · doi:10.5772/22813

Síndrome hipereosinofílico y síndrome de Churg-Strauss ¿Espectro de una misma enfermedad? Nuevos conceptos

López-Piedrahíta, E., Ramírez-Giraldo, R. H., Franco, C. J. V., Tamayo-Quijano, L. M., Pinto-Peñaranda, L. F., Márquez-Hernández, J. D., Chinchilla, C., & Villa, R. C. (2014) · Acta Médica Colombiana · doi:10.36104/amc.2014.281

Churg-Strauss sindromas

Krivickaitė, M., Orlovskytė, T., Chomičienė, A., Grigaitienė, J., Meškauskas, R., & Bylaitė-Bučinskienė, M. (2013) · Sveikatos mokslai · doi:10.5200/sm-hs.2013.120

A 77 year old man with asthma and renal impairment

Owen, C., Clark, S. G., & Woolfson, R. G. (2015) · BMJ · doi:10.1136/bmj.h2021

Immunomodulation thérapeutique au cours des vascularites systémiques : état des lieux

Puéchal, X., & Guillevin, L. (2012) · Revue du Rhumatisme · doi:10.1016/j.rhum.2012.10.010

Hyperéosinophilies chroniques inexpliquées et syndromes hyperéosinophiliques

Kahn, J., Schoindre, Y., Legrand, F., Blétry, O., & Ackermann, F. (2011) · Revue des Maladies Respiratoires Actualités · doi:10.1016/s1877-1203(11)70025-8

Fresh from the designation pipeline: orphan drugs recently designated in the European Union (March – April 2013)

Antoniu, S. A. (2013) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2013.830570

Pharmacological approach to treating eosinophilic granulomatosis with polyangiitis (Churg–Strauss)

Groh, M., Dunogué, B., & Guillevin, L. (2015) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2015.1025748

Asthma bronchiale und Churg-Strauss-Syndrom

Schreiber, J. (2013) · Der Pneumologe · doi:10.1007/s10405-013-0710-7

To summarize the current knowledge about the role of interleukins in selected paediatric pulmonary diseases To summarize the biology of interleukins active in paediatric pulmonary diseases To review human trials of therapies aimed at interleukins that are involved in lung disease To help prepare the paediatric pulmonary community to understand and evaluate current and future interleukin-related therapies

Rozycki, H. J., & Zhao, W. (2014)

Cas clinique n° 1 Un asthme hyperéosinophilique

BOURDIN, A. A. (2013) · Revue des Maladies Respiratoires Actualités · doi:10.1016/s1877-1203(13)70364-1

Immunomodulation thérapeutique dans la granulomatose éosinophilique avec polyangéite (Churg-Strauss)

Puéchal, X. (2015) · Revue du Rhumatisme · doi:10.1016/j.rhum.2015.10.001

Therapeutic Use of Biologic Agents in Systemic Vasculitides

Anthonypillai, J., & Ambrus, J. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-40136-2_34

Biologic Therapy for Eosinophilic Granulomatosis With Polyangiitis (Churg‐Strauss): Comment on the Article by Jachiet et al

Novikov, P. I., & Moiseev, S. V. (2016) · Arthritis & Rheumatology · doi:10.1002/art.40015

Glomerulonephritis – Do We Have Promising Role of Monoclonal Antibodies?

Sharma, S., & Saxena, S. (2016) · Journal of Clinical & Experimental Nephrology · doi:10.21767/2472-5056.100023

Vascularites associées aux anticorps anticytoplasme des polynucléaires neutrophiles

Charles, P., Guillevin, L., & Terrier, B. (2017)

Eosinophilic Granulomatosis with Polyangiitis: The Beginning of a New Era

Moreno, C. M., Blanco, M. C., & Campos, R. M. D. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.89054

A pediatric case of eosinophilic granulomatosis with polyangiitis accompanied by heart failure mimicking an asthma attack

Kim, M. J., Lee, B., Park, J. S., Choi, Y. J., Song, M. K., Lee, S., & Suh, D. I. (2019) · Allergy Asthma & Respiratory Disease · doi:10.4168/aard.2019.7.4.212

Eosinophilic granulomatosis with polyangiitis

Cottin, V., Ahmad, K., Nasser, M., Valenzuela, C., Groh, M., Terrier, B., & Traclet, J. (2019) · European Respiratory Society eBooks · doi:10.1183/2312508x.10014819

Antieosinophil Therapeutics

(2012) · Elsevier eBooks · doi:10.1016/b978-0-12-394385-9.00015-8

Treatment of Vasculitis: Beyond the Basics

Ghauri, M. I., & Mukarram, M. S. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.92729

Particularités de la granulomatose éosinophilique avec polyangéite (ex-syndrome de Churg-Strauss)

Terrier, B. (2020) · Revue des Maladies Respiratoires Actualités · doi:10.1016/s1877-1203(20)30734-5

3.Churg-Strauss Syndrome(アレルギー性肉芽腫性血管炎)の最近の治療 : 免疫グロブリン大量療法を含めて(VIII.アレルギー・免疫疾患の新規治療薬と治療法,専門医のためのアレルギー学講座)

谷口, 正. (2010) · アレルギー · doi:10.15036/arerugi.59.923

Biologics in ANCA-Associated Vasculitides

Jha, S., & Sharma, A. (2022) · Springer eBooks · doi:10.1007/978-981-16-7200-2_10

Reply

Jachiet, M., & Terrier, B. (2016) · Arthritis & Rheumatology · doi:10.1002/art.40009

Eosinophils

Scher, J. U., Abramson, S. B., & Pillinger, M. H. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-1738-9.00012-8

Hypereosinophiliesyndrome

Houriet, C., Simon, H., & Simon, D. (2014) · Aktuelle Dermatologie · doi:10.1055/s-0034-1365078

Asthma or eosinophilic granulomatosis with polyangiitis: a case-based reviewPreprint

Wang, P., Liu, Y., Shao, M., & Chen, D. (2022) · Research Square · doi:10.21203/rs.3.rs-2118285/v1

Pulmonary Vasculitides

Kaous, M., Sargsyan, L. A., Palacio, D. M., Febbo, J., Ketai, L. H., Gilman, M. D., de Groot, P. M., Truong, M. T., & Moran, C. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-21040-2_21

The Impact of Churg–Strauss Syndrome on Nasal Function and Quality of Life: An Underexplored Dimension

Galassi, L., & Facchinetti, F. (2025) · Sinusitis · doi:10.3390/sinusitis9010003

Mise à jour sur l’immunomodulation thérapeutique des vascularites associées aux ANCA

Puéchal, X. (2025) · Revue du Rhumatisme · doi:10.1016/j.rhum.2025.10.006

A case report of eosinophilic granulomatosis with polyangiitis in children with cerebella infarction as the first symptom and literature review

Chen, D., He, X., Shen, Y., Gao, Y., Chen, D., Hang, S., Wang, X., Li, N., & Xu, D. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1682325

Management of Eosinophilic Granulomatosis with Polyangiitis with less myocardial involvement Using Early Mepolizumab without Immunosuppressants: Clinical ImplicationsPreprint

Masumoto, N., Yamashita, Y., Nakashima, T., Kodama, Y., Terada, K., Masumitsu, H., Miyasaka, A., Muraoka, T., Kaneko, T., & Tsurikisawa, N. (2026) · Research Square · doi:10.21203/rs.3.rs-8484790/v1

Mepolizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A scoping review of effectiveness and safety data derived from real-world evidence

Rúa‐Figueroa, Í., Velasco, B., & Cid, M. C. (2026) · Autoimmunity Reviews · doi:10.1016/j.autrev.2026.104080

Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Eosinophilic Granulomatosis With Polyangiitis Presenting With Refractory Asthma, Mononeuritis Multiplex, and Cutaneous Vasculitis: A Case Report

Malkawi, K., Beynon, J., & Rupani, H. (2026) · Cureus · doi:10.7759/cureus.110239

EGPA at Diagnosis: A Comprehensive Single-Center Profile of Laboratory Findings and Clinical Evidence

Brunetto, S., Dimasi, F., Maiolo, C., Zumbo, E., Buta, F., Gangemi, S., & Ricciardi, L. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27167116

Factors Associated with Successful Immunosuppressant Discontinuation After Mepolizumab Initiation in Eosinophilic Granulomatosis with PolyangiitisPreprint

Masumoto, N., Yamashita, Y., Takaoka, S., Nakashima, T., Matsunaga, K., Kodama, Y., Terada, K., Masumitsu, H., Miyasaka, A., Muraoka, T., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10555256/v1

Identification of clinical-biological endophenotypes in patients with eosinophilic granulomatosis with polyangiitis using unsupervised machine learning: a real-world study

Kim, G., Wang, Z., Li, Y., Zhao, R., Shen, K., Lian, H., Liu, Y., Lin, J., & Ni, X. (2026) · Respiratory Research · doi:10.1186/s12931-026-03800-5

Mepolizumab as a Steroid-Sparing Treatment in the Churg Strauss Syndrome.

Sh, K., Israel, E., Oren, E., & Wechsler, M. E. (2009) · doi:10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a5468 · Cited by 2

Oral glucocorticoid-sparing effects of mepolizumab. A real-life study.

Bjerrum, A., Schmid, J., & Skjold, T. (2018) · doi:10.1183/13993003.congress-2018.pa601 · Cited by 2

Efficacy and safety of mepolizumab in eosinophilic granulomatosis with polyangiitis: Insights from real-life cases and literature analysis.

Cassone, G., Sebastiani, M., Cataleta, P., Olivi, E., Gurioli, C., Cerri, S., Beghé, B., Giuggioli, D., & Manfredi, A. (2025) · Sarcoidosis vasculitis and diffuse lung diseases · doi:10.36141/svdld.v42i1.16311 · Cited by 1

Rationale and design of a placebo-controlled trial to evaluate the steroid-sparing effects of anti-IL5 monoclonal antibody (mepolizumab): Focus on cutaneous outcomes in patients with hypereosinophilic syndrome (HES)

(2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.10.347

Late-breaking abstract: Oral corticosteroid-sparing effect of mepolizumab in severe eosinophilic asthma: The SIRIUS study

Bel, E. H., Wenzel, S., Thompson, P. J., Prazma, C. M., Keene, O. N., Yancey, S., Ortega, H., & Pavord, I. D. (2014) · European Respiratory Journal · doi:10.1183/13993003/erj.44.suppl_58.2907 · Cited by 10